HUMATROPE

This brand name is authorized in Australia, Austria, Canada, Finland, France, Japan, Lithuania, Netherlands, South Africa, Spain, UK.

Active ingredients

The drug HUMATROPE contains one active pharmaceutical ingredient (API):

1	Somatropin human recombinant UNII NQX9KB6PCL - SOMATROPIN
	Somatropin is a potent metabolic hormone of importance for the metabolism of lipids, carbohydrates and proteins. In children with inadequate endogenous growth hormone, somatropin stimulates linear growth and increases growth rate. In adults, as well as in children, somatropin maintains a normal body composition by increasing nitrogen retention and stimulation of skeletal muscle growth, and by mobilization of body fat.
	Read more about Somatropin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
H01AC01	Somatropin	H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01A Anterior pituitary lobe hormones and analogues → H01AC Somatropin and somatropin agonists
Discover more medicines within H01AC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10429X, 10461N, 10476J, 10482Q, 10487Y, 10502R, 6169Q, 6170R, 6345Y
CA	Health Products and Food Branch	00745626, 02243077, 02243078, 02243079
ES	Centro de información online de medicamentos de la AEMPS	60421, 60422, 60423
FI	Lääkealan turvallisuus- ja kehittämiskeskus	045005, 045021, 045039
FR	Base de données publique des médicaments	64156624, 65675287, 67079617
GB	Medicines & Healthcare Products Regulatory Agency	41674, 45053, 91195
JP	医薬品医療機器総合機構	2412402L1031, 2412402L4049
LT	Valstybinė vaistų kontrolės tarnyba	1000914, 1000915
NL	Z-Index G-Standaard	13842900, 13842919, 13842927
NL	Z-Index G-Standaard, PRK	35122, 39608, 39616
ZA	Health Products Regulatory Authority	32/21.10/0673, 33/21.10/0310